Structured evidence table for Sage Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sage Cognition Randomized Trial | In this edition of the Huntington's Disease Clinical Trials Update, we expand on the launch of the phase II/III clinical trial of SKY-0515 from Skyhawk Therapeutics and the phase I/II clinical trial of SPK-10001 from Spark Therapeutics. | 2 | Farag M (2025) | Huntington's disease clinical trials update: October 2025. |
| Sage Cognition Randomized Trial | We also report positive topline data from uniQure's phase I/II clinical trial of AMT-130 after 36 months of follow-up. | 2 | Farag M (2025) | Huntington's disease clinical trials update: October 2025. |
Source documents